Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 144

1.

Histopathology - guided mass spectrometry differentiates benign nevi from malignant melanoma.

Lazova R, Smoot K, Anderson H, Powell MJ, Rosenberg AS, Rongioletti F, Pilloni L, D'Hallewin S, Gueorguieva R, Tantcheva-Poór I, Obadofin O, Camacho C, Hsi A, Kluger HH, Fadare O, Seeley EH.

J Cutan Pathol. 2019 Nov 7. doi: 10.1111/cup.13610. [Epub ahead of print]

PMID:
31697431
2.

The Association of Impulsivity and Family History of Alcohol Use Disorder on Alcohol Use and Consequences.

Haeny AM, Gueorguieva R, Morean ME, Krishnan-Sarin S, DeMartini KS, Pearlson GD, Anticevic A, Krystal JH, O'Malley SS.

Alcohol Clin Exp Res. 2019 Nov 6. doi: 10.1111/acer.14230. [Epub ahead of print]

PMID:
31693193
3.

Transitions Across Tobacco Use Profiles Among Adolescents: Results from the Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 2.

Simon P, Buta E, Gueorguieva R, Kong G, Morean ME, Camenga D, Bold KW, Krishnan-Sarin S.

Addiction. 2019 Oct 16. doi: 10.1111/add.14828. [Epub ahead of print]

PMID:
31618491
4.

Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.

Krishnan-Sarin S, O'Malley SS, Franco N, Cavallo DA, Tetrault JM, Shi J, Gueorguieva R, Pittman B, Krystal JH.

Neuropsychopharmacology. 2020 Jan;45(2):319-326. doi: 10.1038/s41386-019-0536-z. Epub 2019 Oct 7.

PMID:
31590179
5.

Examining sex as a predictor and moderator of treatment outcomes for binge-eating disorder: Analysis of aggregated randomized controlled trials.

Lydecker JA, Gueorguieva R, Masheb R, White MA, Grilo CM.

Int J Eat Disord. 2019 Sep 9. doi: 10.1002/eat.23167. [Epub ahead of print]

PMID:
31497876
6.

Adolescents' awareness of the nicotine strength and e-cigarette status of JUUL e-cigarettes.

Morean ME, Bold KW, Kong G, Gueorguieva R, Camenga DR, Simon P, Jackson A, Cavallo DA, Krishnan-Sarin S.

Drug Alcohol Depend. 2019 Nov 1;204:107512. doi: 10.1016/j.drugalcdep.2019.05.032. Epub 2019 Aug 24.

PMID:
31487572
7.

Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled Trial.

Martino S, Zimbrean P, Forray A, Kaufman JS, Desan PH, Olmstead TA, Gilstad-Hayden K, Gueorguieva R, Yonkers KA.

J Gen Intern Med. 2019 Nov;34(11):2520-2529. doi: 10.1007/s11606-019-05257-3. Epub 2019 Aug 29.

PMID:
31468342
8.

Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.

Chen MH, Cheng CM, Gueorguieva R, Lin WC, Li CT, Hong CJ, Tu PC, Bai YM, Tsai SJ, Krystal JH, Su TP.

Neuropsychopharmacology. 2019 Nov;44(12):2112-2118. doi: 10.1038/s41386-019-0480-y. Epub 2019 Aug 17.

PMID:
31421635
9.

Tobacco use increases risk of food insecurity: An analysis of continuous NHANES data from 1999 to 2014.

Mayer M, Gueorguieva R, Ma X, White MA.

Prev Med. 2019 Sep;126:105765. doi: 10.1016/j.ypmed.2019.105765. Epub 2019 Jun 29.

PMID:
31260724
10.

Bayesian joint modelling of longitudinal data on abstinence, frequency and intensity of drinking in alcoholism trials.

Buta E, O'Malley SS, Gueorguieva R.

J R Stat Soc Ser A Stat Soc. 2018 Jun;181(3):869-888. doi: 10.1111/rssa.12334. Epub 2017 Nov 6.

11.

Examining race as a predictor and moderator of treatment outcomes for binge-eating disorder: Analysis of aggregated randomized controlled trials.

Lydecker JA, Gueorguieva R, Masheb R, White MA, Grilo CM.

J Consult Clin Psychol. 2019 Jun;87(6):530-540. doi: 10.1037/ccp0000404. Epub 2019 Apr 22.

PMID:
31008634
12.

Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial.

Abdallah CG, Roache JD, Averill LA, Young-McCaughan S, Martini B, Gueorguieva R, Amoroso T, Southwick SM, Guthmiller K, López-Roca AL, Lautenschlager K, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH; Consortium to Alleviate PTSD.

Contemp Clin Trials. 2019 Jun;81:11-18. doi: 10.1016/j.cct.2019.04.009. Epub 2019 Apr 15.

PMID:
30999057
13.

Modulation of 'Protective' Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-Cigarettes.

DeVito EE, Jensen KP, O'Malley SS, Gueorguieva R, Krishnan-Sarin S, Valentine G, Jatlow PI, Sofuoglu M.

Nicotine Tob Res. 2019 Apr 17. pii: ntz057. doi: 10.1093/ntr/ntz057. [Epub ahead of print]

PMID:
30995302
14.

Targeting neuroinflammation with minocycline in heavy drinkers.

Petrakis IL, Ralevski E, Gueorguieva R, Sloan ME, Devine L, Yoon G, Arias AJ, Sofuoglu M.

Psychopharmacology (Berl). 2019 Oct;236(10):3013-3021. doi: 10.1007/s00213-019-05205-3. Epub 2019 Mar 27.

PMID:
30919006
15.

Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking.

Bold KW, Zweben A, Fucito LM, Piepmeier ME, Muvvala S, Wu R, Gueorguieva R, O'Malley SS.

Alcohol Clin Exp Res. 2019 May;43(5):937-944. doi: 10.1111/acer.13994. Epub 2019 Mar 21.

PMID:
30817018
16.

Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.

Verplaetse TL, Ralevski E, Roberts W, Gueorguieva R, McKee SA, Petrakis IL.

Alcohol Clin Exp Res. 2019 Apr;43(4):741-746. doi: 10.1111/acer.13969. Epub 2019 Feb 19.

PMID:
30698839
17.

Altered functional connectivity and low-frequency signal fluctuations in early psychosis and genetic high risk.

Tang Y, Zhou Q, Chang M, Chekroud A, Gueorguieva R, Jiang X, Zhou Y, He G, Rowland M, Wang D, Fu S, Yin Z, Leng H, Wei S, Xu K, Wang F, Krystal JH, Driesen NR.

Schizophr Res. 2019 Aug;210:172-179. doi: 10.1016/j.schres.2018.12.041. Epub 2019 Jan 23.

PMID:
30685394
18.

Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant.

Wilkinson ST, Farmer C, Ballard ED, Mathew SJ, Grunebaum MF, Murrough JW, Sos P, Wang G, Gueorguieva R, Zarate CA Jr.

Neuropsychopharmacology. 2019 Jun;44(7):1233-1238. doi: 10.1038/s41386-019-0317-8. Epub 2019 Jan 17.

PMID:
30653192
19.

Correction: Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.

Su TP, Chen MH, Li CT, Lin WC, Hong CJ, Gueorguieva R, Tu PC, Bai YM, Cheng CM, Krystal JH.

Neuropsychopharmacology. 2019 Feb;44(3):655-656. doi: 10.1038/s41386-018-0253-z.

20.

Sleep improvements and associations with default mode network functional connectivity following rTMS for generalized anxiety disorder.

Diefenbach GJ, Rabany L, Hallion LS, Tolin DF, Goethe JW, Gueorguieva R, Zertuche L, Assaf M.

Brain Stimul. 2019 Jan - Feb;12(1):184-186. doi: 10.1016/j.brs.2018.09.004. Epub 2018 Sep 12. No abstract available.

PMID:
30269922

Supplemental Content

Loading ...
Support Center